comparemela.com

Latest Breaking News On - Defeat alcoholic steatohepatitis - Page 1 : comparemela.com

DURECT Corporation (NASDAQ:DRRX) Q2 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the DURECT Corporation Second Quarter Earnings Call. [Operator Instructions]. It is now my pleasure to introduce your host, Tim Papp, Chief Financial Officer.

San diegoUnited statesNew yorkMontefiore einsteinJames brownAntonio arceEd arceKristen kluskaKeith luiTim pappPaul gaglioWeiqi linRichard millerFrancois briseboisSean kimJim brown

DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update

/PRNewswire/ DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2023 and provided a corporate update..

United statesPaul gaglioJamese brownDrug administrationExchange commissionCorporation nasdaqSteatohepatitis consortiumInnocoll pharmaceuticals ltdInnocoll pharmaceuticalsEarnings call todayBusiness highlightsOpinion leaderBrett fortuneAmerican journalDefeat alcoholic steatohepatitisFast track designation

DURECT Corporation (NASDAQ:DRRX) Q1 2023 Earnings Call Transcript

Operator: Greetings and welcome to the DURECT Corporation First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

United kingdomUnited statesNew yorkColumbia universityBrian leeWeiqi linFrancois briseboisPaul gaglioNorman sussmanEd arceJim brownTim pappKristen kluskaKeith luiSean kimDurect corporation

DURECT Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2a Study of Larsucosterol in Alcohol-Associated Hepatitis

/PRNewswire/ DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company focused on developing epigenetic modulator programs for the treatment of acute.

United statesUniversity of california san diegoJamese brownCraig mcclainTarek hassaneinUniversity scholar at of louisvilleDrug administrationInnocoll pharmaceuticalsSouthern california research centerSteatohepatitis consortiumInnocoll pharmaceuticals ltdExchange commissionCorporation nasdaqAmerican journalDefeat alcoholic steatohepatitisObservational arm

vimarsana © 2020. All Rights Reserved.